UROY
Uranium Royalty CorpUROY
UROY
About: Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.
Employees: 14
0
Funds holding %
of 7,202 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
83% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 12
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
5% more funds holding
Funds holding: 64 [Q4 2024] → 67 (+3) [Q1 2025]
1.07% more ownership
Funds ownership: 17.06% [Q4 2024] → 18.13% (+1.07%) [Q1 2025]
6% less call options, than puts
Call options by funds: $671K | Put options by funds: $714K
14% less capital invested
Capital invested by funds: $50.1M [Q4 2024] → $43M (-$7.1M) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$4.50
137%
upside
Avg. target
$4.50
137%
upside
High target
$4.50
137%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Heiko Ihle | 137%upside $4.50 | Buy Maintained | 22 Apr 2025 |
Financial journalist opinion
Neutral
PRNewsWire
6 months ago
Uranium Royalty Announces Appointment of New Director
DESIGNATED NEWS RELEASE VANCOUVER, BC , Oct. 29, 2024 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce that Mr. Ken Robertson has been appointed as a director of the Company.
Neutral
PRNewsWire
6 months ago
Uranium Royalty Acquires Existing Royalty on Cameco's Advanced Stage Millennium and Cree Extension Uranium Projects
DESIGNATED NEWS RELEASE VANCOUVER, BC , Oct. 28, 2024 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce that it acquired an existing royalty on the Millennium and Cree Extension Uranium Projects in Saskatchewan, Canada (the "Projects") from a third-party industrial gas company for total cash consideration of $6 million. Highlights: The acquired royalty is a net profit interest (NPI) of 10% on an approximate 20.6955% participating interest in the Projects.
Neutral
PRNewsWire
7 months ago
Uranium Royalty Announces Voting Results and Appointment of Director
DESIGNATED NEWS RELEASE VANCOUVER, BC , Oct. 17, 2024 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce that at its annual general and special meeting held on October 17, 2024 (the "Meeting" or "AGSM"), all nominees listed in its management information circular dated August 23, 2024 were elected as directors of the Company. Each of the following five nominees proposed by management was elected as a director on a vote by show of hands.
Positive
Benzinga
7 months ago
2 Uranium Stocks Fueling Growth From the Nuclear Power Surge
Uranium stocks have been surging thanks to the Constellation Energy Co. CEG and Microsoft Co. deal for the largest power-purchasing deal in history. The large hyperscalers are committed to sustainable and clean energy solutions to power their data centers.
Positive
MarketBeat
7 months ago
2 Uranium Stocks Fueling Growth From the Nuclear Power Surge
Uranium stocks have been surging thanks to the Constellation Energy Co. NASDAQ: CEG and Microsoft Co. NASDAQ: MSFT deal for the largest power-purchasing deal in history. The large hyperscalers are committed to sustainable and clean energy solutions to power their data centers.
Negative
Seeking Alpha
8 months ago
Uranium Royalty: Speculative Play On The Bull At A Good Price
Uranium Royalty stock is now at a valuation where intelligent investors can speculate on potential upside. Uranium Royalty stock has underperformed compared to peers, but its current valuation offers a floor via its uranium inventory. Covered calls offer a way to offset multitudes of the cash burn while trying to make money.
Neutral
PRNewsWire
9 months ago
Uranium Energy Announces Succession of Chief Financial Officer
NYSE American – UEC CORPUS CHRISTI, Texas , Aug. 9, 2024 /PRNewswire/ - Uranium Energy Corp (NYSE American: UEC) or (the "Company") announced today that Josephine Man has joined the Company and will be succeeding Pat Obara as Treasurer and Chief Financial Officer, effective October 1, 2024. Mr. Obara, who joined the Company in 2006, will be stepping down from his current role as Chief Financial Officer on October 1, 2024 after the filing of the Company's Annual Report on Form 10-K for the current fiscal year and will continue with the Company as Senior Vice-President, Administration.
Neutral
PRNewsWire
9 months ago
Uranium Royalty Corp. Completes Acquisition of Additional Royalty on the Churchrock Uranium Project, New Mexico, USA
DESIGNATED NEWS RELEASE VANCOUVER, BC , Aug. 1, 2024 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) ("URC" or the "Company") is pleased to announce the completion of its previously announced acquisition of an additional royalty on a portion of the Churchrock uranium project ("Churchrock Project") owned indirectly by Laramide Resources Ltd. ("Laramide") in New Mexico, USA.
Neutral
PRNewsWire
9 months ago
Uranium Royalty Corp. Acquires Additional Royalty on the Churchrock Uranium Project, New Mexico, USA
VANCOUVER, BC , July 29, 2024 /PRNewswire/ - Uranium Royalty Corp. (NASDAQ: UROY, TSX: URC) ("URC" or the "Company") is pleased to announce that it has entered into a binding royalty purchase agreement to acquire an additional royalty on a portion of the Churchrock uranium project ("Churchrock Project" or the "Project") owned indirectly by Laramide Resources Ltd. ("Laramide") in New Mexico, USA.
Neutral
Seeking Alpha
11 months ago
The 'Undercovered' Dozen From June 1-6
The "Undercovered" Dozen highlights twelve ideas from the previous month on stocks with limited coverage. Biotechs CRISPR Therapeutics, Voyager Therapeutics, and Alnylam Pharmaceuticals are covered along with Enovix, Uranium Royalty, Clover Health, and Haliburton. Many of the ideas included have not been discussed in months on the site. One of the ideas is actually first-ever coverage for this ticker.
Charts implemented using Lightweight Charts™